Gupta, Kapil http://orcid.org/0000-0002-2115-3503
Toelzer, Christine http://orcid.org/0000-0001-9984-5940
Williamson, Maia Kavanagh
Shoemark, Deborah K. http://orcid.org/0000-0002-1240-8463
Oliveira, A. Sofia F. http://orcid.org/0000-0001-8753-4950
Matthews, David A. http://orcid.org/0000-0003-4611-8795
Almuqrin, Abdulaziz
Staufer, Oskar http://orcid.org/0000-0002-8015-3132
Yadav, Sathish K. N.
Borucu, Ufuk
Garzoni, Frederic
Fitzgerald, Daniel
Spatz, Joachim http://orcid.org/0000-0003-3419-9807
Mulholland, Adrian J. http://orcid.org/0000-0003-1015-4567
Davidson, Andrew D.
Schaffitzel, Christiane http://orcid.org/0000-0002-1516-9760
Berger, Imre http://orcid.org/0000-0001-7518-9045
Funding for this research was provided by:
Wellcome Trust (106115/Z/14/Z)
RCUK | Engineering and Physical Sciences Research Council (EP/R013764/1, EP/R511663/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/P000940/1, BB/L01386X/1)
Article History
Received: 28 June 2021
Accepted: 16 December 2021
First Online: 11 January 2022
Competing interests
: F.G. and I.B. report shareholding in Imophoron Ltd, unrelated to this Correspondence. D.F. and I.B. report shareholding in Geneva Biotech SARL, unrelated to this Correspondence. C.S., D.F., and I.B. report shareholding in Halo Therapeutics Ltd related to this Correspondence. Patent applications describing methods, material compositions and formulations based on the present observations have been filed. The remaining authors declare no competing interests.